help button home button Endocrine Society JCEM ENDO 08
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, J.
Right arrow Articles by Lee, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, J.
Right arrow Articles by Lee, Y.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 7 3510-3515
Copyright © 2004 by The Endocrine Society

Ginsenoside-Rb1 from Panax ginseng C.A. Meyer Activates Estrogen Receptor-{alpha} and -ß, Independent of Ligand Binding

JungYoon Cho, Wankyu Park, SeungKi Lee, Woongshick Ahn and YoungJoo Lee

College of Life Science (JY.C., W.P., YJ.L.), Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea; College of Pharmacy (SK.L.), Seoul National University, Seoul 151-742, Korea; and Department of Obstetrics and Gynecology (W.A.), Catholic Research Institutes of Medical Science, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea

Address all correspondence and requests for reprints to: YoungJoo Lee, Ph.D., Department of Bioscience and Biotechnology, Sejong University, Kwang-Jin-Gu, Seoul 143-747, Korea. E-mail: yjlee{at}sejong.ac.kr.

We studied the estrogenic activity of a component of Panax ginseng, ginsenoside-Rb1. The activity of ginsenoside-Rb1 was characterized in a transient transfection system, using estrogen receptor isoforms and estrogen-responsive luciferase plasmids, in COS monkey kidney cells. Ginsenoside-Rb1 activated both {alpha} and ß estrogen receptors in a dose-dependent manner with maximal activity observed at 100 µM, the highest concentration examined. Activation was inhibited by the estrogen receptor antagonist ICI 182,780, indicating that the effects were mediated through the estrogen receptor. Treatment with 17ß-estradiol or ginsenoside-Rb1 increased expression of the progesterone receptor, pS2, and estrogen receptor in MCF-7 cells and of AP-1-driven luciferase genes in COS cells. Although these data suggest that it is functionally very similar to 17ß-estradiol, ginsenoside-Rb1 failed to displace specific binding of [3H]17ß-estradiol from estrogen receptors in MCF-7 whole-cell ligand binding assays. Our results indicate that the estrogen-like activity of ginsenoside-Rb1 is independent of direct estrogen receptor association.

This work was supported in part by grants from the Korean Science and Engineering Foundation (2000-20700-005-3; SK.L.), Korea Tobacco and Ginseng Corp. R&D Program 2000 (YJ.L.), Korean Ministry of Health and Welfare (HMP-00-O-21600-0009 to YJ.L.), and BK21 program (YJ.L.).

JY.C. and W.P. contributed equally to this work.

Abbreviations: CD-FBS, Charcoal-dextran stripped fetal bovine serum; E2, 17ß-estradiol; ER, estrogen receptor; ERE, estrogen-responsive element; PR, progesterone receptor.




This article has been cited by other articles:


Home page
Integr Cancer TherHome page
M. L. King, S. R. Adler, and L. L. Murphy
Extraction-Dependent Effects of American Ginseng (Panax quinquefolium) on Human Breast Cancer Cell Proliferation and Estrogen Receptor Activation.
Integr Cancer Ther, September 1, 2006; 5(3): 236 - 243.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
Y. Cui, X.-O. Shu, Y.-T. Gao, H. Cai, M.-H. Tao, and W. Zheng
Association of Ginseng Use with Survival and Quality of Life among Breast Cancer Patients
Am. J. Epidemiol., April 1, 2006; 163(7): 645 - 653.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society